Stocks & Investing
Thu, June 13, 2024
[ Thu, Jun 13th 2024
] - WOPRAI
Tue, September 26, 2023
[ Tue, Sep 26th 2023
] - WOPRAI
Tue, August 22, 2023
[ Tue, Aug 22nd 2023
] - WOPRAI
Thu, August 17, 2023
[ Thu, Aug 17th 2023
] - WOPRAI
Mon, December 5, 2022
[ Mon, Dec 05th 2022
] - WOPRAI
Thu, January 27, 2022
[ Thu, Jan 27th 2022
] - WOPRAI
Wed, June 30, 2021
[ Wed, Jun 30th 2021
] - WOPRAI
Mon, December 14, 2020
[ Mon, Dec 14th 2020
] - WOPRAI
Fri, August 28, 2020
Thu, May 7, 2020
[ Thu, May 07th 2020
] - WOPRAI
Tue, July 2, 2019
[ Tue, Jul 02nd 2019
] - WOPRAI
Tue, November 6, 2018
[ Tue, Nov 06th 2018
] - WOPRAI
Wed, August 8, 2018
[ Wed, Aug 08th 2018
] - WOPRAI
Thu, July 12, 2018
[ Thu, Jul 12th 2018
] - WOPRAI
Tue, June 12, 2018
[ Tue, Jun 12th 2018
] - WOPRAI
Fri, December 16, 2016
[ Fri, Dec 16th 2016
] - WOPRAI
Brandon Folkes Initiated (TRVI) at Strong Buy and Held Target at $7 on, Jun 13th, 2024
Brandon Folkes of Rodman & Renshaw, Initiated "Trevi Therapeutics, Inc." (TRVI) at Strong Buy and Held Target at $7 on, Jun 13th, 2024.
Brandon has made no other calls on TRVI in the last 4 months.
There are 2 other peers that have a rating on TRVI. Out of the 2 peers that are also analyzing TRVI, 0 agree with Brandon's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Brandon
- Serge Belanger of "Needham" Reiterated at Strong Buy and Held Target at $8 on, Wednesday, May 8th, 2024
- Leland Gershell of "Oppenheimer" Maintained at Buy and Held Target at $9 on, Thursday, March 21st, 2024
